1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Langelaan, D.N.
Rainey, J.K.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J Phys Chem Lett
1948-7185
8
2381
2386
10.1021/acs.jpclett.7b00867
28492329
Preserved Transmembrane Segment Topology, Structure, and Dynamics in Disparate Micellar Environments.
2017
0000-0003-0793-5573
10.2210/pdb2low/pdb
pdb_00002low
7306.109
Apelin receptor
UNP residues 1-55
1
man
polymer
Angiotensin receptor-like 1, G-protein coupled receptor APJ, G-protein coupled receptor HG11
no
no
MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRKKGHHHHHH
MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFRKKGHHHHHH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
APLNR, AGTRL1, APJ
9606
Homo sapiens
562
Escherichia coli
pEXP5-CT
Solution NMR structure of the N-terminus and first transmembrane segment of the apelin receptor solubilised in 50% HFIP/50% water
database_2
pdbx_database_status
pdbx_nmr_software
pdbx_nmr_spectrometer
struct_ref_seq_dif
citation
citation_author
repository
Initial release
Database references
Data collection
Database references
Other
Database references
1
0
2013-01-16
1
1
2017-05-24
1
2
2023-06-14
1
3
2023-07-26
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
_struct_ref_seq_dif.details
_citation.journal_volume
_citation_author.identifier_ORCID
BMRB
Y
RCSB
2012-01-27
REL
REL
REL
REL
structures with the lowest energy
100
40
2D 1H-13C HSQC/HMQC
3D HNCO
HNcaCO (H[N[ca[CO]]])
3D HNCA
HNcoCACB (H[N[co[{CA|ca[C]}]]])
3D HNCA
3D HN(CO)CA
3D 1H-15N TOCSY
3D 1H-15N NOESY
3D HCCH-TOCSY
3D 1H-13C NOESY
HSQC_NOESY_125ms_HSQC (h[C]_H[N].NOESY)
15NHSQC
.9
mM
[U-99% 13C; U-99% 15N]
50
%
[U-99% 2H]
1
mM
5
mM
[U-99% 2H]
40
%
10
%
[U-99% 2H]
310
K
simulated annealing, torsion angle dynamics
1
extended conformation
.9 mM [U-99% 13C; U-99% 15N] AR55, 50 % [U-99% 2H] hexafluoroisopropanol, 1 mM DSS, 5 mM [U-99% 2H] DTT, 40 % H2O, 10 % [U-99% 2H] D2O, 50% Hexafluoroisopropanol/40% H2O /10% D2O
50% Hexafluoroisopropanol/40% H2O /10% D2O
CCPN
chemical shift assignment
CcpNmr Analysis
2.2
CCPN
peak picking
CcpNmr Analysis
2.2
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
processing
NMRPipe
Schwieters, Kuszewski, Tjandra and Clore
structure solution
X-PLOR NIH
Schwieters, Kuszewski, Tjandra and Clore
refinement
X-PLOR NIH
700
Bruker
AVANCE III
Bruker Avance III
MET
1
n
1
MET
1
A
GLU
2
n
2
GLU
2
A
GLU
3
n
3
GLU
3
A
GLY
4
n
4
GLY
4
A
GLY
5
n
5
GLY
5
A
ASP
6
n
6
ASP
6
A
PHE
7
n
7
PHE
7
A
ASP
8
n
8
ASP
8
A
ASN
9
n
9
ASN
9
A
TYR
10
n
10
TYR
10
A
TYR
11
n
11
TYR
11
A
GLY
12
n
12
GLY
12
A
ALA
13
n
13
ALA
13
A
ASP
14
n
14
ASP
14
A
ASN
15
n
15
ASN
15
A
GLN
16
n
16
GLN
16
A
SER
17
n
17
SER
17
A
GLU
18
n
18
GLU
18
A
CYS
19
n
19
CYS
19
A
GLU
20
n
20
GLU
20
A
TYR
21
n
21
TYR
21
A
THR
22
n
22
THR
22
A
ASP
23
n
23
ASP
23
A
TRP
24
n
24
TRP
24
A
LYS
25
n
25
LYS
25
A
SER
26
n
26
SER
26
A
SER
27
n
27
SER
27
A
GLY
28
n
28
GLY
28
A
ALA
29
n
29
ALA
29
A
LEU
30
n
30
LEU
30
A
ILE
31
n
31
ILE
31
A
PRO
32
n
32
PRO
32
A
ALA
33
n
33
ALA
33
A
ILE
34
n
34
ILE
34
A
TYR
35
n
35
TYR
35
A
MET
36
n
36
MET
36
A
LEU
37
n
37
LEU
37
A
VAL
38
n
38
VAL
38
A
PHE
39
n
39
PHE
39
A
LEU
40
n
40
LEU
40
A
LEU
41
n
41
LEU
41
A
GLY
42
n
42
GLY
42
A
THR
43
n
43
THR
43
A
THR
44
n
44
THR
44
A
GLY
45
n
45
GLY
45
A
ASN
46
n
46
ASN
46
A
GLY
47
n
47
GLY
47
A
LEU
48
n
48
LEU
48
A
VAL
49
n
49
VAL
49
A
LEU
50
n
50
LEU
50
A
TRP
51
n
51
TRP
51
A
THR
52
n
52
THR
52
A
VAL
53
n
53
VAL
53
A
PHE
54
n
54
PHE
54
A
ARG
55
n
55
ARG
55
A
LYS
56
n
56
LYS
56
A
LYS
57
n
57
LYS
57
A
GLY
58
n
58
GLY
58
A
HIS
59
n
59
HIS
59
A
HIS
60
n
60
HIS
60
A
HIS
61
n
61
HIS
61
A
HIS
62
n
62
HIS
62
A
HIS
63
n
63
HIS
63
A
HIS
64
n
64
HIS
64
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
A
HD21
H
ASN
TYR
9
10
1.26
7
A
A
HD21
H
ASN
TYR
9
10
1.30
20
A
A
HD21
H
ASN
TYR
9
10
1.33
1
A
ASP
6
-172.57
58.61
1
A
ASN
9
45.22
-171.28
1
A
TYR
10
55.53
116.52
1
A
ALA
33
-56.41
-70.58
1
A
LEU
40
-66.47
2.61
1
A
LEU
41
-100.61
-63.22
1
A
THR
44
-134.99
-50.68
1
A
HIS
60
-137.45
-92.87
1
A
HIS
61
-150.79
-63.67
1
A
HIS
62
-168.86
114.02
2
A
GLU
2
-50.58
95.85
2
A
GLU
3
-57.51
-172.67
2
A
ASP
6
178.16
70.86
2
A
ASN
9
-41.52
-82.15
2
A
TYR
10
-40.63
157.20
2
A
GLU
18
-59.56
-74.85
2
A
TRP
24
-38.06
-34.76
2
A
LEU
40
-63.46
0.01
2
A
ASN
46
-126.80
-50.62
2
A
HIS
61
-102.49
-153.95
2
A
HIS
62
-99.36
-70.24
2
A
HIS
63
-100.79
42.71
3
A
GLU
2
57.26
-175.07
3
A
GLU
3
49.73
-166.39
3
A
ASP
6
-170.71
54.83
3
A
TYR
10
-72.62
37.24
3
A
TYR
11
-162.62
39.70
3
A
ASN
15
-49.83
-13.63
3
A
GLU
18
-56.41
-5.65
3
A
LEU
30
-137.28
-31.78
3
A
LEU
40
-64.70
0.59
3
A
THR
44
-136.79
-51.33
3
A
VAL
49
-60.20
-72.74
3
A
HIS
60
-55.99
-109.29
3
A
HIS
61
-152.11
-55.67
3
A
HIS
62
-156.59
-44.41
3
A
HIS
63
-98.22
41.69
4
A
GLU
3
-172.49
56.16
4
A
ASP
6
-149.62
47.48
4
A
TYR
10
-62.97
70.27
4
A
ALA
13
-131.80
-31.82
4
A
ALA
29
-105.16
41.51
4
A
LEU
30
-174.00
-28.51
4
A
LEU
37
-46.91
-17.60
4
A
LEU
40
-65.95
1.45
4
A
LEU
41
-101.22
-61.03
4
A
THR
44
-135.94
-51.26
4
A
HIS
62
77.97
-34.92
5
A
GLU
3
-174.16
-167.49
5
A
ASN
9
-46.17
-79.48
5
A
GLU
18
-49.54
-14.09
5
A
ALA
29
-144.54
-3.94
5
A
LEU
30
-137.87
-34.52
5
A
ALA
33
-54.12
-72.05
5
A
LEU
41
-49.98
-71.14
5
A
THR
43
-48.20
-13.19
5
A
VAL
49
-62.15
-74.99
5
A
HIS
62
-80.52
-78.93
5
A
HIS
63
-93.70
41.84
6
A
ASP
6
-146.69
44.93
6
A
ASN
9
-54.24
176.35
6
A
TYR
11
-174.20
39.93
6
A
GLU
18
-58.99
-77.03
6
A
SER
27
-92.52
30.34
6
A
LEU
30
-147.62
-36.03
6
A
THR
43
-150.96
27.11
6
A
VAL
49
-59.82
-71.66
6
A
PHE
54
-48.87
-12.78
6
A
HIS
62
54.38
106.75
7
A
ASP
6
-175.40
57.09
7
A
PHE
7
62.67
134.60
7
A
ASN
9
47.68
-178.02
7
A
TYR
10
-49.26
88.81
7
A
ASN
15
-47.69
-15.99
7
A
LEU
40
-64.22
1.13
7
A
LEU
41
-99.05
-65.82
7
A
THR
44
-136.36
-50.87
7
A
VAL
49
-60.13
-72.33
7
A
HIS
62
-62.80
-92.13
7
A
HIS
63
-88.70
41.24
8
A
ASP
6
-149.85
55.42
8
A
TYR
10
58.52
142.34
8
A
LEU
37
-49.08
-11.81
8
A
LEU
41
-103.86
-63.87
8
A
THR
44
-138.09
-47.91
8
A
PHE
54
-49.25
-12.45
8
A
HIS
61
-94.71
36.82
8
A
HIS
62
75.50
-64.11
9
A
ASP
6
-171.67
53.42
9
A
ASP
8
41.57
21.99
9
A
ASN
9
-49.10
-97.76
9
A
TYR
11
78.83
40.17
9
A
GLU
18
-47.74
-14.91
9
A
ALA
29
-92.52
43.52
9
A
LEU
30
-172.65
-28.41
9
A
LEU
40
-63.29
0.41
9
A
LEU
41
-96.06
-67.78
9
A
THR
44
-140.31
-55.87
9
A
VAL
49
-60.16
-70.61
9
A
HIS
61
-67.13
-148.25
10
A
GLU
3
-56.08
178.40
10
A
ASP
6
-172.33
67.87
10
A
PHE
7
64.07
156.44
10
A
ASN
9
-45.95
173.09
10
A
TYR
10
52.69
109.88
10
A
TYR
11
79.31
40.87
10
A
ASP
23
-98.64
-60.14
10
A
SER
27
-136.17
-53.55
10
A
THR
43
-144.31
23.20
10
A
THR
44
-132.44
-48.07
10
A
VAL
49
-60.69
-72.06
10
A
PHE
54
-49.31
-14.90
10
A
HIS
62
-73.33
-80.80
10
A
HIS
63
-98.96
42.35
11
A
GLU
3
53.79
169.24
11
A
ASP
6
-148.89
54.22
11
A
ASN
9
-41.83
-88.99
11
A
TYR
11
74.54
40.46
11
A
ALA
29
-145.70
-4.82
11
A
LEU
30
-137.07
-33.75
11
A
ALA
33
-53.21
-74.56
11
A
THR
43
-148.42
20.74
11
A
THR
44
-132.20
-47.85
11
A
VAL
49
-61.25
-71.16
11
A
HIS
62
67.52
-66.86
11
A
HIS
63
-98.06
42.60
12
A
ASP
6
-160.70
57.48
12
A
ASN
9
41.07
-100.21
12
A
TYR
11
72.10
38.11
12
A
LEU
30
-177.35
-27.03
12
A
LEU
37
-57.76
-9.45
12
A
THR
43
-46.02
-14.20
12
A
ASN
46
-139.86
-45.23
12
A
HIS
60
-142.90
38.58
12
A
HIS
61
-68.60
-176.61
12
A
HIS
62
-81.15
-74.46
12
A
HIS
63
-94.38
41.16
13
A
GLU
3
55.47
84.49
13
A
PHE
7
-80.06
39.78
13
A
ASP
8
-148.67
24.90
13
A
TYR
10
-71.70
38.48
13
A
TYR
11
-168.43
40.93
13
A
GLU
18
-59.20
-6.85
13
A
LEU
30
-136.07
-31.50
13
A
LEU
40
-68.75
0.57
13
A
THR
43
-140.19
28.86
13
A
THR
44
-135.20
-50.09
13
A
VAL
49
-60.80
-72.16
13
A
HIS
61
-82.48
34.37
13
A
HIS
62
76.96
-63.45
13
A
HIS
63
-76.57
42.58
14
A
GLU
3
48.59
72.24
14
A
ASP
6
-141.54
42.38
14
A
ASN
9
-48.90
170.29
14
A
TYR
10
58.59
142.11
14
A
ALA
33
-54.89
-70.53
14
A
THR
43
-149.94
18.63
14
A
HIS
60
-95.56
-98.45
15
A
GLU
3
-178.95
-179.76
15
A
ASP
6
-144.08
48.70
15
A
ASP
8
44.31
27.72
15
A
ASN
9
-41.65
-77.11
15
A
TYR
10
-41.92
154.54
15
A
THR
43
-64.19
2.90
15
A
HIS
60
-140.85
24.20
15
A
HIS
62
81.89
-136.21
15
A
HIS
63
-72.95
38.41
16
A
GLU
3
70.35
129.64
16
A
ASP
6
-156.77
59.15
16
A
PHE
7
53.24
83.63
16
A
ASP
8
-146.59
46.07
16
A
ASN
9
41.51
-108.79
16
A
LEU
41
-102.32
-62.85
16
A
THR
44
-135.20
-48.64
16
A
HIS
61
-71.75
-150.86
16
A
HIS
62
-80.86
-80.86
16
A
HIS
63
-97.74
43.50
17
A
GLU
3
43.98
-168.87
17
A
ASP
6
-144.51
41.60
17
A
PHE
7
-59.78
105.42
17
A
ASP
8
-146.14
-42.53
17
A
ASN
9
49.45
-84.18
17
A
TYR
10
-70.06
38.98
17
A
TYR
11
-172.98
38.26
17
A
ALA
29
-93.53
43.41
17
A
LEU
30
-172.60
-28.14
17
A
LEU
40
-64.07
0.44
17
A
THR
44
-136.10
-52.36
17
A
VAL
49
-60.91
-73.25
17
A
HIS
60
-53.10
-83.25
17
A
HIS
61
61.16
-71.68
18
A
GLU
3
-178.63
-177.64
18
A
ASP
6
-151.19
57.16
18
A
PHE
7
-48.20
176.47
18
A
ASP
8
-63.34
0.99
18
A
TYR
10
-63.23
70.45
18
A
ALA
13
-137.59
-35.44
18
A
ALA
29
-93.70
43.00
18
A
LEU
30
-172.32
-28.46
18
A
THR
43
-152.55
26.73
18
A
VAL
49
-60.35
-71.84
18
A
HIS
60
-66.88
-123.67
19
A
GLU
3
-172.57
93.52
19
A
PHE
7
-73.84
47.33
19
A
ASN
9
-52.78
171.09
19
A
TYR
10
52.80
109.04
19
A
TYR
11
79.74
40.94
19
A
LEU
30
-137.56
-30.78
19
A
LEU
37
-55.49
-5.80
19
A
THR
44
-130.68
-48.63
19
A
PHE
54
-49.30
-12.53
19
A
HIS
61
-64.83
-123.13
19
A
HIS
62
-98.62
-72.87
20
A
ASP
6
178.36
61.71
20
A
ASN
9
37.94
-122.55
20
A
TYR
10
-38.82
125.57
20
A
TYR
11
79.19
37.88
20
A
LEU
30
-153.85
-36.71
20
A
ALA
33
-62.93
-70.31
20
A
LEU
40
-63.20
0.99
20
A
LEU
41
-95.33
-74.01
20
A
THR
44
-129.44
-50.10
20
A
HIS
60
-67.20
-108.81
20
A
HIS
61
-162.33
-90.64
20
A
HIS
62
-140.71
-31.13
21
A
GLU
3
-57.81
171.62
21
A
ASP
6
-156.84
60.15
21
A
ASP
8
-155.97
32.90
21
A
ASN
9
-52.64
-80.38
21
A
GLU
18
-56.64
-5.30
21
A
ASP
23
-137.15
-35.52
21
A
ALA
29
-93.16
31.82
21
A
LEU
30
-168.96
-34.45
21
A
LEU
40
-65.54
0.96
21
A
LEU
41
-98.32
-60.74
21
A
THR
44
-136.32
-51.60
21
A
HIS
60
-79.52
35.20
21
A
HIS
61
-56.12
-110.57
21
A
HIS
62
-102.31
-69.52
22
A
GLU
3
62.09
-171.46
22
A
ASP
6
-177.81
67.95
22
A
PHE
7
-51.33
170.34
22
A
ASN
9
41.36
-93.19
22
A
TYR
10
-41.89
154.93
22
A
ALA
29
-93.59
42.29
22
A
LEU
30
-171.14
-28.72
22
A
THR
43
-146.96
11.80
22
A
ASN
46
-135.87
-44.62
22
A
HIS
60
-101.95
-70.06
22
A
HIS
61
78.37
-144.33
22
A
HIS
62
-60.57
-99.55
22
A
HIS
63
-73.00
40.41
23
A
GLU
2
42.42
-164.68
23
A
GLU
3
60.53
161.56
23
A
ASP
6
-163.65
43.85
23
A
ASN
9
-41.54
-77.99
23
A
TYR
10
-43.04
155.58
23
A
GLU
18
-41.38
-73.85
23
A
ALA
29
-93.44
43.30
23
A
LEU
30
-173.14
-28.42
23
A
LEU
41
-101.64
-61.99
23
A
THR
44
-136.52
-46.91
23
A
VAL
49
-59.93
-72.42
23
A
HIS
61
-98.83
-82.92
24
A
GLU
3
-172.88
145.63
24
A
ASP
6
-148.20
42.28
24
A
PHE
7
-151.24
74.36
24
A
ASP
8
41.52
22.03
24
A
ASN
9
-58.89
172.23
24
A
TYR
11
-174.35
39.87
24
A
SER
27
-94.34
31.19
24
A
LEU
30
-143.97
-36.49
24
A
LEU
40
-62.87
0.03
24
A
LEU
41
-94.25
-69.18
24
A
THR
44
-137.33
-51.72
24
A
VAL
49
-58.97
-70.44
24
A
HIS
60
-69.50
-118.50
24
A
HIS
61
-160.30
-31.60
24
A
HIS
62
-170.24
141.98
25
A
GLU
3
-48.08
151.87
25
A
ASP
8
-146.02
14.50
25
A
TYR
10
58.67
140.43
25
A
ALA
29
-92.39
41.46
25
A
LEU
30
-172.26
-28.32
25
A
THR
44
-133.18
-48.74
25
A
VAL
49
-61.39
-70.95
25
A
HIS
62
55.41
-82.57
25
A
HIS
63
-88.14
41.03
26
A
GLU
2
53.09
-177.16
26
A
GLU
3
-172.76
45.32
26
A
ASP
6
-151.01
58.08
26
A
PHE
7
-73.89
-162.82
26
A
TYR
10
-70.96
39.73
26
A
TYR
11
-164.46
41.07
26
A
GLU
18
-46.30
-72.76
26
A
SER
27
-96.44
32.82
26
A
LEU
30
-153.40
-35.77
26
A
THR
43
-158.26
19.73
26
A
HIS
60
-84.15
-98.42
26
A
HIS
61
56.32
-78.71
27
A
GLU
3
-173.10
99.21
27
A
ASP
8
-155.36
52.96
27
A
ASN
9
49.41
178.06
27
A
TYR
10
-47.16
90.02
27
A
SER
27
-92.66
30.38
27
A
LEU
30
-147.21
-36.53
27
A
VAL
49
-59.70
-71.29
27
A
HIS
61
-89.87
39.91
27
A
HIS
62
69.69
130.21
28
A
GLU
3
-61.48
73.38
28
A
ASP
6
-156.02
56.40
28
A
ASN
9
-56.12
-169.74
28
A
TYR
10
52.02
105.84
28
A
SER
17
-122.49
-52.37
28
A
SER
27
-102.92
48.52
28
A
LEU
30
-172.99
-29.38
28
A
THR
43
-47.79
-12.33
28
A
ASN
46
-139.86
-46.27
28
A
HIS
60
-96.93
59.09
28
A
HIS
62
66.55
105.27
29
A
GLU
2
-175.75
67.15
29
A
ASP
8
-159.67
-47.54
29
A
ASN
9
33.56
-89.38
29
A
GLU
18
-41.61
-71.55
29
A
ALA
29
-92.72
41.98
29
A
LEU
30
-174.11
-28.20
29
A
THR
44
-131.84
-42.49
29
A
ASN
46
-123.37
-54.59
29
A
VAL
49
-59.20
-71.03
29
A
HIS
60
-89.80
-116.95
29
A
HIS
61
-154.88
-66.29
29
A
HIS
62
-162.76
-59.69
29
A
HIS
63
-101.82
42.06
30
A
GLU
3
-57.52
171.78
30
A
ASP
6
-160.35
54.57
30
A
PHE
7
59.78
112.45
30
A
ASN
9
42.53
-158.55
30
A
TYR
10
48.33
-152.96
30
A
TYR
11
-59.44
74.52
30
A
SER
17
-91.55
-60.13
30
A
LEU
30
-174.50
-28.99
30
A
ALA
33
-44.61
-71.66
30
A
LEU
37
-46.94
-14.57
30
A
THR
44
-131.16
-48.36
30
A
VAL
49
-60.78
-70.93
30
A
HIS
62
-97.28
-60.92
30
A
HIS
63
-101.03
41.62
31
A
ASP
6
-162.72
55.37
31
A
PHE
7
-85.18
44.00
31
A
ASP
8
-101.27
43.19
31
A
ASN
9
-51.06
175.25
31
A
TYR
10
58.46
128.64
31
A
LEU
40
-65.38
1.85
31
A
LEU
41
-99.46
-65.93
31
A
THR
44
-135.07
-50.19
31
A
HIS
62
55.19
-83.12
31
A
HIS
63
-88.06
41.11
32
A
GLU
2
46.90
-164.96
32
A
ASP
6
-141.48
43.63
32
A
PHE
7
54.12
167.25
32
A
ASN
9
45.73
-172.87
32
A
TYR
10
41.76
94.45
32
A
TYR
11
78.64
41.97
32
A
GLU
18
-48.91
-12.74
32
A
ALA
29
59.57
16.06
32
A
ALA
33
-55.60
-71.07
32
A
LEU
40
-69.14
1.02
32
A
ASN
46
-133.82
-62.52
32
A
HIS
62
-174.06
-102.61
32
A
HIS
63
-100.82
43.49
33
A
GLU
2
54.88
-173.38
33
A
ASP
6
-151.82
45.86
33
A
PHE
7
-41.17
95.64
33
A
ASN
9
52.53
167.83
33
A
TYR
10
37.47
31.37
33
A
TYR
11
-174.32
39.54
33
A
TRP
24
-37.98
-33.73
33
A
SER
27
-108.84
48.91
33
A
LEU
30
-168.03
-28.80
33
A
ASN
46
-123.72
-59.47
33
A
VAL
49
-60.96
-70.41
33
A
HIS
62
58.37
127.49
34
A
GLU
2
41.79
-162.57
34
A
ASP
6
-159.95
60.29
34
A
PHE
7
47.41
-167.20
34
A
ASN
9
41.34
-94.56
34
A
LEU
30
-144.42
-36.00
34
A
ASN
46
-135.26
-43.54
34
A
VAL
49
-60.67
-71.63
34
A
HIS
59
-165.06
22.11
34
A
HIS
60
40.21
26.94
34
A
HIS
61
-102.89
-135.57
34
A
HIS
62
-100.94
-79.90
34
A
HIS
63
-100.47
43.66
35
A
GLU
3
-172.57
56.79
35
A
PHE
7
-159.50
87.09
35
A
ASP
8
-150.81
14.62
35
A
ASN
9
-59.67
-92.55
35
A
GLU
18
-46.72
-18.65
35
A
ASP
23
-125.85
-56.15
35
A
SER
27
-96.55
31.08
35
A
LEU
30
-153.07
-36.33
35
A
THR
43
-51.96
-6.71
35
A
ASN
46
-153.78
-52.96
35
A
HIS
61
-145.41
-157.98
35
A
HIS
62
-93.45
-66.06
35
A
HIS
63
-97.51
41.40
36
A
GLU
3
63.31
151.52
36
A
ASP
6
174.19
72.94
36
A
ASP
8
42.95
22.81
36
A
TYR
10
-71.15
40.50
36
A
TYR
11
-169.64
38.26
36
A
GLU
18
-56.58
-5.81
36
A
ALA
29
-144.70
-2.40
36
A
LEU
30
-139.15
-34.71
36
A
THR
44
-140.31
-59.96
36
A
HIS
62
-167.58
-65.83
36
A
HIS
63
-101.12
42.73
37
A
GLU
2
46.78
80.01
37
A
ASP
6
-173.08
66.93
37
A
ASP
8
-158.70
19.70
37
A
TYR
10
-71.10
39.87
37
A
TYR
11
-168.97
40.51
37
A
HIS
61
-62.79
-80.43
37
A
HIS
62
-142.46
-82.20
37
A
HIS
63
-86.96
40.25
38
A
GLU
3
53.44
-172.20
38
A
ASN
9
-57.82
-170.16
38
A
TYR
10
44.09
97.16
38
A
TYR
11
71.61
39.30
38
A
LEU
30
-158.46
17.78
38
A
LEU
41
-131.27
-37.57
38
A
THR
44
-136.96
-52.43
38
A
HIS
60
-77.34
40.20
38
A
HIS
62
-154.60
-65.75
38
A
HIS
63
-100.70
42.04
39
A
GLU
2
-101.01
79.20
39
A
GLU
3
-57.58
-179.62
39
A
ASP
6
-159.15
50.16
39
A
PHE
7
-52.85
101.30
39
A
ASN
9
42.19
-129.75
39
A
ALA
13
-136.73
-34.76
39
A
ALA
29
-93.91
43.47
39
A
LEU
30
-172.82
-28.10
39
A
LEU
40
-64.59
1.10
39
A
LEU
41
-99.40
-66.36
39
A
THR
44
-134.80
-51.05
39
A
ASN
46
-102.47
-61.39
39
A
HIS
59
-168.65
20.42
39
A
HIS
62
-66.39
-78.87
39
A
HIS
63
-92.30
39.26
40
A
GLU
2
-165.23
71.81
40
A
GLU
3
-173.06
42.71
40
A
ASP
6
-150.70
46.55
40
A
ASP
8
-152.86
40.59
40
A
ASN
9
-43.58
168.44
40
A
TYR
10
58.46
143.31
40
A
SER
17
-136.89
-48.46
40
A
ALA
29
-103.03
41.71
40
A
LEU
30
-159.45
-32.92
40
A
ASN
46
-134.29
-50.64
40
A
PHE
54
-48.88
-13.26
40
A
HIS
61
-99.40
55.70
40
A
HIS
62
59.62
117.48
Extended conformation, model 10
Solution structure of AR55 in 50% HFIP
1
N
N
A
GLU
20
A
GLU
20
HELX_P
A
GLY
28
A
GLY
28
1
1
9
A
LEU
30
A
LEU
30
HELX_P
A
THR
43
A
THR
43
1
2
14
A
GLY
45
A
GLY
45
HELX_P
A
LYS
57
A
LYS
57
1
3
13
MEMBRANE PROTEIN
MEMBRANE PROTEIN
APJ_HUMAN
UNP
1
1
P35414
MEEGGDFDNYYGADNQSECEYTDWKSSGALIPAIYMLVFLLGTTGNGLVLWTVFR
1
55
2LOW
1
55
P35414
A
1
1
55
1
expression tag
LYS
56
2LOW
A
P35414
UNP
56
1
expression tag
LYS
57
2LOW
A
P35414
UNP
57
1
expression tag
GLY
58
2LOW
A
P35414
UNP
58
1
expression tag
HIS
59
2LOW
A
P35414
UNP
59
1
expression tag
HIS
60
2LOW
A
P35414
UNP
60
1
expression tag
HIS
61
2LOW
A
P35414
UNP
61
1
expression tag
HIS
62
2LOW
A
P35414
UNP
62
1
expression tag
HIS
63
2LOW
A
P35414
UNP
63
1
expression tag
HIS
64
2LOW
A
P35414
UNP
64